Vera Therapeutics, Inc. Increase (Decrease) in Other Current Assets
Vera Therapeutics, Inc. (VERA) reported Increase (Decrease) in Other Current Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-10
- Vera Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $0.00.
- Vera Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $0.00.
- Vera Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$1.00K.
- Vera Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $108.00K.
- Vera Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2025 was -$51.00K.
- Vera Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2024 was -$351.00K, a 233.97% decline from fiscal 2023.
- Vera Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2023 was $262.00K, a 136.04% increase from fiscal 2022.
- Vera Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2022 was $111.00K, a 117.65% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 9 month as first filed | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | -$1.00K derived: sum of 3 quarters · filed 2026-08-10 | $107.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | -$1.00K derived: sum of 2 quarters · filed 2026-05-07 | $107.00K derived: sum of 3 quarters · filed 2026-05-07 | -$34.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $107.00K derived: sum of 2 quarters · filed 2026-02-26 | -$34.00K derived: sum of 3 quarters · filed 2026-08-10 | -$51.00K 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$33.00K derived: sum of 2 quarters · filed 2026-08-10 | -$50.00K 10-Q · filed 2025-11-05 | -$59.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$158.00K 10-Q · filed 2026-08-10 | -$167.00K derived: sum of 3 quarters · filed 2026-08-10 | -$487.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$17.00K 10-Q · filed 2026-05-07 | -$26.00K derived: sum of 2 quarters · filed 2026-05-07 | -$346.00K derived: sum of 3 quarters · filed 2026-05-07 | -$359.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$329.00K derived: sum of 2 quarters · filed 2026-02-26 | -$342.00K derived: sum of 3 quarters · filed 2026-02-26 | -$351.00K 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$333.00K derived: sum of 2 quarters · filed 2025-11-05 | -$342.00K 10-Q · filed 2025-11-05 | -$343.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$22.00K 10-Q · filed 2025-08-05 | -$23.00K derived: sum of 3 quarters · filed 2026-02-26 | -$34.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-07 | -$10.00K derived: sum of 2 quarters · filed 2026-02-26 | -$21.00K derived: sum of 3 quarters · filed 2026-02-26 | $249.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$12.00K derived: sum of 2 quarters · filed 2026-02-26 | $258.00K derived: sum of 3 quarters · filed 2026-02-26 | $262.00K 10-K · filed 2026-02-26 | $309.00K 10-K · filed 2024-03-27 | |||
| 2023-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $259.00K derived: sum of 2 quarters · filed 2024-11-07 | $263.00K 10-Q · filed 2024-11-07 | $308.00K 10-Q · filed 2023-11-09 | $276.00K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $274.00K 10-Q · filed 2024-08-08 | $304.00K 10-Q · filed 2023-08-10 | $287.00K derived: sum of 3 quarters · filed 2024-08-08 | $353.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-10 | $5.00K 10-Q · filed 2023-05-11 | $17.00K derived: sum of 2 quarters · filed 2024-05-10 | $83.00K derived: sum of 3 quarters · filed 2024-05-10 | $386.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $79.00K derived: sum of 2 quarters · filed 2024-03-27 | $382.00K derived: sum of 3 quarters · filed 2024-03-27 | $111.00K 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $369.00K derived: sum of 2 quarters · filed 2023-11-09 | $98.00K 10-Q · filed 2023-11-09 | $149.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $32.00K 10-Q · filed 2023-08-10 | $83.00K derived: sum of 3 quarters · filed 2023-08-10 | $83.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$271.00K 10-Q · filed 2023-05-11 | -$220.00K derived: sum of 2 quarters · filed 2023-05-11 | -$220.00K derived: sum of 3 quarters · filed 2023-05-11 | -$220.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $51.00K derived: sum of 2 quarters · filed 2023-03-28 | $51.00K derived: sum of 3 quarters · filed 2023-03-28 | $51.00K 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | ||||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | -$59.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |